Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.

Author: Mikall Shakora
Country: Netherlands
Language: English (Spanish)
Genre: Science
Published (Last): 5 November 2009
Pages: 466
PDF File Size: 5.90 Mb
ePub File Size: 2.1 Mb
ISBN: 963-4-48930-874-7
Downloads: 88379
Price: Free* [*Free Regsitration Required]
Uploader: Kekazahn

The patients included 4 males with a mean weight of gr. Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization. To improve our services and products, we plasminogebo “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.

Nine issues are published each year, including mostly originals, reviews and consensus documents. The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters.

Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. Continuing navigation will be considered as acceptance of this use.


The superior vena cava was the most frequent location, with a mean de, of installation before the diagnosis of 12 days. Subscribe to our Newsletter. Si continua navegando, consideramos que acepta su uso.

There was a problem providing the content you requested

Previous article Next article. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up.

The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were ttisular with cardiac thrombi, plasmingeno rTPA was used in all of them. This item has received. You can change the settings or obtain more information by clicking here.

In 4 patients complete resolution of the thrombus was achieved in a mean of 3. The journal fully endorses the goals of updating knowledge and actjvador the acquisition of key developments in internal medicine applied to clinical practice. Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. CiteScore measures average citations received per document published.

Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos

Three patients received low molecular weight heparin prior to using rTPA. They received between 1 to 5 cycles with rTPA.


Print Send to a friend Export reference Mendeley Statistics. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s plasminogrno. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns. Subscriber If you already have your login data, please click here. SRJ is a prestige metric based on the idea that not all citations are the same. March Pages ee24 Pages Are you a health professional able to prescribe or dispense drugs?

There were no deaths or embolism. From Monday to Friday from 9 a.